The Magnetic Resonance Biophysics Group conducts pioneering work at the intersection of advanced neuroimaging and therapeutic neuroscience. Their research program explores two interconnected domains that push the boundaries of brain science and clinical applications.
At the core of their work lies sophisticated functional MRI (fMRI) technology that captures the brain's activity patterns through the BOLD contrast mechanism. This approach detects minute magnetic differences between oxygen-rich and oxygen-poor blood, revealing how neural activation evolves every 1-3 seconds with exceptional spatial precision. The group has developed specialized protocols that not only pinpoint functional brain areas but also decode the dynamic conversations between neural networks during cognitive tasks. Their work provides fundamental insights into neuroplasticity - the brain's remarkable ability to reorganize itself - while creating new frameworks for neurorehabilitation. A particularly promising direction involves fusing fMRI with complementary neuroimaging tools to unravel the brain's complex functional architecture and develop neural interface technologies.
The group's groundbreaking trimodal platform merges real-time fMRI, EEG monitoring, and neurofeedback into a unified system for brain training and rehabilitation. This technology allows patients to literally see their brain activity while learning to modulate specific neural circuits, harnessing the brain's innate plasticity for therapeutic benefit. Their clinical work has yielded notable successes, including motor function recovery in chronic stroke patients through targeted fMRI neurofeedback protocols. The innovative "Vira!" game interface, where users control virtual environments through physiological signals, unexpectedly revealed the cerebellum's role in cognitive control processes. These technologies are being adapted for diverse neurological and psychiatric conditions, from movement disorders to depression and addiction, demonstrating how direct neural interface training can reshape dysfunctional brain networks.
By combining rigorous basic neuroscience with translational clinical research, the group is creating both new understanding of brain function and practical tools for neurological care. Their work exemplifies how cutting-edge imaging technology can bridge the gap between laboratory discoveries and real-world therapeutic applications, offering hope for patients with various brain disorders.
The group's integrated approach continues to advance both the science of brain imaging and its clinical implementation, demonstrating how fundamental research can translate into meaningful improvements in neurological care.
